Valuation: Neuland Laboratories Limited

Market Cap 281B 2.93B 2.58B 2.43B 2.22B 4.14B 4.18B 29.14B 11.29B 143B 10.99B 10.76B 466B P/E 2027 *
58.8x
P/E 2028 * 45x
Enterprise Value 284B 2.95B 2.6B 2.45B 2.24B 4.18B 4.21B 29.4B 11.39B 144B 11.09B 10.85B 470B EV / Sales 2027 *
11.6x
EV / Sales 2028 * 9.64x
Free-Float
62.26%
Yield 2027 *
0.11%
Yield 2028 * 0.14%
1 day-2.60%
1 week-3.28%
Current month-4.47%
1 month-5.95%
3 months+21.17%
6 months+89.70%
Current year+44.23%
1 week 21,848.15
Extreme 21848.15
23,030.95
1 month 21,848.15
Extreme 21848.15
24,235.05
Current year 11,500
Extreme 11500
24,235.05
1 year 11,500
Extreme 11500
24,235.05
3 years 3,612.05
Extreme 3612.05
24,235.05
5 years 965.85
Extreme 965.85
24,235.05
10 years 247.3
Extreme 247.3
24,235.05
Manager TitleAgeSince
Chief Executive Officer 47 01/04/2026
Director of Finance/CFO - 23/11/2022
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 50 01/01/2002
Chairman 82 07/01/1984
Director/Board Member 47 01/03/2007
Change 5-day change 1-year change 3-year change Capi.($)
-2.60%-3.28%+46.57%+501.11% 3.01B
+2.68%+2.56%+59.32%+114.00% 1,026B
+0.56%+0.17%+53.19%+68.90% 649B
+0.02%+0.42%+20.51%+71.43% 468B
+0.06%+0.25%+37.03%+45.71% 352B
+1.16%+4.10%+21.99%+29.39% 271B
-0.24%+2.18%+10.14%+12.26% 256B
-0.01%+6.91%+45.42%+52.15% 220B
-1.11%-0.80%+31.69%+100.04% 188B
+0.30%-7.19%-32.43%-60.56% 170B
Average +0.18%+1.06%+29.34%+93.44% 360.21B
Weighted average by Cap. +1.06%+1.25%+38.06%+67.67%

Financials

2027 *2028 *
Net sales 24.43B 255M 224M 211M 193M 360M 363M 2.53B 982M 12.44B 956M 935M 40.47B 29.27B 305M 268M 253M 231M 431M 435M 3.03B 1.18B 14.89B 1.14B 1.12B 48.47B
Net income 4.8B 49.99M 43.97M 41.45M 37.82M 70.72M 71.27M 497M 193M 2.44B 188M 184M 7.95B 6.26B 65.26M 57.4M 54.11M 49.37M 92.33M 93.05M 649M 252M 3.19B 245M 240M 10.38B
Net Debt 2.56B 26.68M 23.47M 22.12M 20.18M 37.75M 38.04M 265M 103M 1.3B 100M 98M 4.24B 979M 10.2M 8.97M 8.46M 7.72M 14.43M 14.55M 102M 39.34M 498M 38.31M 37.47M 1.62B
Logo Neuland Laboratories Limited
Neuland Laboratories Ltd. is a global provider of active pharmaceutical ingredients (APIs) contract development and manufacturing organization (CDMO) services. It is focused on manufacture and sale of active pharmaceutical ingredients and allied services. It supports biotechnology and pharmaceutical companies in the design, development and manufacturing of complex APIs. It has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). It develops and manufactures non-exclusive APIs both Prime APIs comprising large volume, mature molecules, and specialty APIs comprising lower volume, complex molecules with less competition. It develops small molecules and peptides for clinical trials and beyond. It provides an end-to-end continuum of customized services from early-stage drug development (Pre-IND) through to commercial manufacturing of complex APIs, including process development, process optimization, analytical testing, and regulatory support.
Employees
2,183
Date Price Change Volume
24/09/26 INR 21,909.40 -2.60% 2,043
23/09/26 INR 22,493.30 -0.16% 1,008
22/09/26 INR 22,529.55 -0.31% 1,686
21/09/26 INR 22,600.70 -1.20% 1,640
18/09/26 INR 22,875.70 +0.97% 4,026
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21,909.40INR
Average target price
24,334.75INR
Spread / Average Target
+11.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEULANDLAB Stock